Avior Wealth Management LLC Sells 1,349 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Avior Wealth Management LLC lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 82.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 295 shares of the company's stock after selling 1,349 shares during the quarter. Avior Wealth Management LLC's holdings in HCA Healthcare were worth $102,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter worth about $1,021,000. Atria Wealth Solutions Inc. increased its position in HCA Healthcare by 28.6% during the fourth quarter. Atria Wealth Solutions Inc. now owns 4,256 shares of the company's stock worth $1,277,000 after purchasing an additional 946 shares during the last quarter. Private Advisor Group LLC boosted its holdings in shares of HCA Healthcare by 28.7% in the 4th quarter. Private Advisor Group LLC now owns 4,354 shares of the company's stock valued at $1,307,000 after purchasing an additional 972 shares during the last quarter. Transcend Capital Advisors LLC boosted its holdings in HCA Healthcare by 6.9% in the fourth quarter. Transcend Capital Advisors LLC now owns 1,310 shares of the company's stock valued at $393,000 after acquiring an additional 85 shares during the last quarter. Finally, Sigma Planning Corp raised its holdings in shares of HCA Healthcare by 25.9% in the 4th quarter. Sigma Planning Corp now owns 714 shares of the company's stock worth $214,000 after purchasing an additional 147 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have recently issued reports on HCA. Morgan Stanley set a $410.00 target price on HCA Healthcare and gave the company an "equal weight" rating in a research note on Monday, June 9th. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Wells Fargo & Company upgraded HCA Healthcare from an "underweight" rating to an "equal weight" rating and raised their target price for the company from $320.00 to $385.00 in a research note on Thursday, May 29th. Finally, Royal Bank Of Canada lifted their price objective on HCA Healthcare from $376.00 to $404.00 and gave the stock an "outperform" rating in a report on Monday. Seven investment analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $394.33.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer now owns 12,646 shares of the company's stock, valued at $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Trading Up 0.1%

Shares of HCA Healthcare stock traded up $0.34 on Tuesday, reaching $379.06. 1,103,292 shares of the company were exchanged, compared to its average volume of 1,469,726. The stock has a fifty day moving average price of $363.94 and a 200-day moving average price of $335.66. The firm has a market capitalization of $91.19 billion, a price-to-earnings ratio of 16.85, a price-to-earnings-growth ratio of 1.31 and a beta of 1.49. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The company had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. During the same period in the previous year, the business earned $5.36 EPS. The company's revenue was up 5.7% on a year-over-year basis. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. HCA Healthcare's payout ratio is 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.